BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6607734)

  • 1. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.
    Steen VD; Ziegler GL; Rodnan GP; Medsger TA
    Arthritis Rheum; 1984 Feb; 27(2):125-31. PubMed ID: 6607734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Rouquette-Gally AM; Stern MH; Prost AC; Abuaf N; Homberg JC; Combrisson A
    Presse Med; 1985 Jul 13-20; 14(28):1497-500. PubMed ID: 2931679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.
    McCarty GA; Rice JR; Bembe ML; Barada FA
    Arthritis Rheum; 1983 Jan; 26(1):1-7. PubMed ID: 6337593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD; Smith CD; Senecal JL; Rothfield N
    Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ; Kinsella TD
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of methods for detection of anticentromere antibodies and other antinuclear antibodies.
    Beutner EH; Krasny SA; Chorzelski TP; Rodnan G; Jablonska S; Kumar V
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):289-95. PubMed ID: 3882784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of the anticentromere antibody.
    Miller MH; Littlejohn GO; Davidson A; Jones B; Topliss DJ
    Br J Rheumatol; 1987 Feb; 26(1):17-21. PubMed ID: 3493051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticentromere antibody and primary pulmonary hypertension.
    Seibold JR; Trontell MC
    J Rheumatol; 1982; 9(4):607-9. PubMed ID: 6752406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL; Medsger TA; Rodnan GP
    J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
    Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
    Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticentromere antibodies in rheumatoid polyarthritis with Sjögren syndrome, without the elements of the CREST syndrome].
    Lorcerie B; Tavernier C; Olsson O; Strauss J; Martin F
    Rev Rhum Mal Osteoartic; 1988 Mar; 55(4):291-2. PubMed ID: 3259719
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration.
    Furst DE; Clements PJ; Saab M; Sterz MG; Paulus HE
    Ann Rheum Dis; 1984 Dec; 43(6):794-801. PubMed ID: 6335385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
    Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcinosis and the anticentromere antibody: its clinical, radiological and immunogenetic aspects.
    Nishikai M; Itoh K; Sato A
    Br J Rheumatol; 1992 Jan; 31(1):9-12. PubMed ID: 1730111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced anticentromere antibody?
    Haberhauer G; Bröll H
    Z Rheumatol; 1989; 48(2):99-100. PubMed ID: 2786663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.
    Steen VD; Powell DL; Medsger TA
    Arthritis Rheum; 1988 Feb; 31(2):196-203. PubMed ID: 3348823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticentromere antibody, CREST and cancer].
    Boyeldieu D; Rouquette-Gally AM; Laugier A; Abuaf N
    Presse Med; 1987 Nov; 16(38):1924-5. PubMed ID: 2962150
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-centromere antibodies (ACA).
    Kallenberg CG
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):136-9. PubMed ID: 2203592
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.
    Bernstein RM; Steigerwald JC; Tan EM
    Clin Exp Immunol; 1982 Apr; 48(1):43-51. PubMed ID: 7044633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.